Shanghai Yifei Biotechnology Co. , Ltd.회사는 제품 목록을 제공합니다.

회사 명:Shanghai Yifei Biotechnology Co. , Ltd.
전화:021-65675885
이메일:customer_service@efebio.com
국적:China
URL: http://www.efebio.com
총 제품 수:11974

제품 카탈로그

Br-PEG4-THP1803547-60-5C13H25BrO5
Fentiazac펜티아작18046-21-4C17H12ClNO2S
YNT-1851804978-81-1C33H37N5O5S
FM041807320-40-6
IACS-010759 hydrochloride1807523-99-4C25H26ClF3N6O4S
TBDMS-PEG4-Acid1807540-77-7C15H32O6Si
Gedivumab1807954-17-1
Lesofavumab1807960-57-1
Gilvetmab1808081-43-7
Linvencorvir1808248-05-6C29H35FN6O5S
NS1-IN-1181373-35-3C23H26N2O4
NTRC 0066-01817791-73-3C33H39N7O2
TAK-4181818252-53-7
Anticonvulsant agent 10 HCl1818253-48-3
GlyT1 Inhibitor 11820934-93-7C22H21N5O2
Lorundrostat1820940-17-7C24H33N7O2
N-Nitroso-N-methylaniline-d51821341-18-7C7H8N2O
BRD24921821669-43-5C20H18N4O2
Acloproxalap1824609-67-7C12H14N2O
TRV-120027 acetate (1234510-46-3 free base)1824712-70-0
CXCR2 antagonist 8182498-30-2C14H13N3O5
Smurf-1 modulator CMP Example 201825371-51-4C23H34N4O5
Gatralimab1826020-80-7
Azintuxizumab1826819-57-1
Talacotuzumab1826831-79-1
Clenoliximab클레놀릭시맙182912-58-9
Idelalisib D51830330-31-8C22H18FN7O
Duvortuxizumab1831098-91-9
Lacnotuzumab1831128-32-5
MLT-9851832576-25-6C17H15Cl2N9O2
L-161240183298-68-2C15H20N2O5
Gantofiban간토피반183547-57-1C21H29N5O6
EGFR-IN-871835666-87-9C28H33N7O2
Rezivertinib1835667-12-3C27H30N6O3
CXCR2-IN-21838123-21-9C18H23ClN2O5S
NS-2710184220-36-8C22H20N4O
NBI-279145-클로로-N-(사이클로프로필메틸)-2-메틸-N-프로필-N'-(2,4,6-트리클로로페닐)-4,6-피리미딘다이아민하이드로콜로라이드(XNUMX-CHLORO-N-(CYCLOPROPYLMETHYL)-XNUMX-METHYL-N-PROPYL-N'-(XNUMX-TRICHLOROPHENYL)-XNUMX-PYRIMIDINEDIAMINEHYDROCHLORIDE)184241-44-9C18H20Cl4N4
Diprogulic acid디케굴락디하이드라트18467-77-1C12H18O7
Setrusumab1847394-95-9
Tibulizumab1849636-24-3
Zavondemstat1851412-93-5C26H29N3O3
PF-066492981854061-16-7C16H22O5
PF-067612811854061-19-0C13H17NO6
Trifluoromethyl-tubercidin1854086-05-7C12H13F3N4O4
Iruplinalkib1854943-32-0C29H38ClN6O2P
Cibisatamab1855925-27-7
Tislelizumab1858168-59-8
Basroparib1858179-75-5C18H21F2N7O3
Edralbrutinib1858206-58-2C26H21F2N5O3
(3S,4S)-PF-064599881858291-14-1C19H22ClN7O3
Tofimilast토피밀라스트185954-27-2C18H21N5S
STC314186295-19-2C13H25NaO32S7
PF-067370071863905-38-7C25H28F4N2O6
Berberine ursodeoxycholate1868138-66-2
Cofetuzumab1869928-62-0
Loncastuximab1875032-68-0
Naxitamab1879925-92-4
JTV-519 fumarate1883549-36-7C29H36N2O6S
Mirikizumab1884201-71-1
HDAC8-IN-20a1884231-52-0C15H15NO4
Cbz-B3A1884710-81-9C35H58N6O9
PB1188714-28-5
EPZ0332941887195-17-6C20H22ClN7O
Dersalazine데살라진188913-58-8C35H32N6O4
HS941892594-93-2C15H15N5O2S
Omburtamab1895083-75-6
MMPP1895957-18-2C17H18O3
Aplindore Fumarate189681-71-8C22H22N2O7
Zamaporvint1900754-56-4C21H16F3N7O
Fmoc-aminooxy-PEG2-NH2190249-87-7C19H22N2O5
1,4-Dideoxy-1,4-epithio-D-ribitol190315-43-6C5H10O3S
Mosunetuzumab1905409-39-3
Iladatuzumab1906205-76-2
Enapotamab1912423-61-0
Ursolic aldehyde19132-81-1C30H48O2
Ezurpimtrostat hydrochloride1914148-73-4C25H32Cl2N4
3-phenylpropanoic-2,2-d2 acidHYDROCINNAMIC-2,2-D2산19136-97-1C9H8D2O2
Tisolagiline1894207-44-3C17H17F3N2O
OPC-1678321883747-71-4C21H20ClF3N2O4
(R)-CJ 11974187281-35-2
TriGalNAc CBz186613-57-0C34H35NO11
Tyrosinase-IN-121860779-42-5C16H12ClN3S
cPrPMEDAP182798-83-0C11H17N6O4P
Tinlarebant1821327-95-0C21H21F5N4O2
ZY-194891821293-40-6C24H32FN9
Cis-22a1819366-84-1C24H30F3N3O2
Resomelagon1809420-71-0C14H14N6O2
YNT-185 dihydrochloride1804978-82-2C33H38ClN5O5S
Propionic-2,2-d2 acid19136-91-5C3H4D2O2
EPZ0325971887193-58-9C20H23N7O
EM1271886879-71-5C14H18ClN3O3
FFN 206 dihydrochloride1883548-88-6C12H15ClN2O2
SU 5616186611-58-5C13H8ClNOS
AY 771835734-92-3C21H32N4O4
SDH-IN-21823354-06-8C10H6F3NO
SMO-IN-21822355-27-0C25H25F4N5O2
CJJ3001807631-83-9C30H33N3
hCYP3A4 Fluorogenic substrate 1186299-00-3C19H12FNO2
Cofrogliptin1844874-26-5C18H19F5N4O3S
(Iso)-Rilmakalim184653-89-2
Copyright 2019 © ChemicalBook. All rights reserved